Japanese bioprinting firm, Cyfuse Biomedical, raises $11.7 million Series B; The intelligent money is on 3D printing of electronics

On 2 March, Cyfuse Biomedical K.K. announced they had completed a 1.4 billion JPY (approximately $11.7 million USD) Series B funding round, with participation from 12 investors, including venture capital funds and corporate investors as well as government support. The Japanese BioPrinting firm has now raised a total of 1.98 billion JPY, which includes a 422 million JPY (approximately $4.77 million USD) Series A back in January 2013.